Barfresh Announces Third Quarter 2025 Results GlobeNewswire November 06, 2025 Record Quarterly Revenue of $4.2 Million, an Increase of 16% Year-Over-Year for Third Quarter 2025 Achieved Positive Adjusted EBITDA and Gross Margin of 37% for Third Quarter 2025 Reiterates Fiscal 2025 Revenue Guidance to $14.5-$15.5 Million and Preliminary Fiscal 2026 Guidance of $30-$35 Million Completes […]
Robinhood Markets, Inc. to Present at the Wolfe Research Wealth Symposium on November 12, 2025 GlobeNewswire November 06, 2025 MENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced that it will be participating in the upcoming Wolfe Research Wealth Symposium on Wednesday, November 12, 2025. Robinhood Chief
Nutanix Announces Date and Conference Call Information for First Quarter Fiscal Year 2026 Financial Results GlobeNewswire November 06, 2025 SAN JOSE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that it will report its financial results for the first quarter of fiscal year 2026,
IBEX Reports Record Start to Fiscal 2026, Raises Full Year Guidance GlobeNewswire November 06, 2025 Record first quarter Revenue, Adjusted EBITDA, EPS, Adjusted EPS, and Free Cash Flow Revenue grew 16.5% versus prior year quarter EPS grew 91% year-over-year to $0.82 and adjusted EPS grew 74% to $0.90 Raises Fiscal Year Guidance WASHINGTON, Nov. 06,
TTEC Announces Third Quarter 2025 GlobeNewswire November 06, 2025 Third Quarter 2025 Revenue was $519.1 Million Net Loss was $11.1 Million or negative 2.1 Percent of Revenue(Net Income of $5.9 Million or 1.1 Percent of Revenue Non-GAAP) Adjusted EBITDA was $43.4 Million or 8.4 Percent of Revenue Reiterates Outlook for Full Year 2025Announces Term Extension
GrowGeneration Reports Third Quarter 2025 Financial Results GlobeNewswire November 06, 2025 Net Loss Improved by $9.0 million Year-Over-Year and Adjusted EBITDA turned positive at $1.3 Million Double-Digit Net Sales Growth of 15.4% Sequentially, Exceeding Guidance at $47.3 million Proprietary Brand Sales Drive Margin Expansion, Rising to 31.6% of Cultivation and Gardening Revenue from 23.8% in
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results GlobeNewswire November 06, 2025 Oncology program advancing with data expected in the fourth quarter 2025 BEACON-IPF close out activities to be completed in the fourth quarter 2025 SOUTH SAN FRANCISCO, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a
Advanced Flower Capital Shareholders Approve Conversion to Business Development Company New Structure is Expected to Position the Company to Pursue Sustainable Growth and Long-Term Shareholder Value GlobeNewswire November 06, 2025 WEST PALM BEACH, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) — Advanced Flower Capital Inc. (Nasdaq: AFCG) (“Advanced Flower Capital”, “AFC” or the “Company”) today announced
CarGurus Announces Third Quarter 2025 Results GlobeNewswire November 06, 2025 Q3'25 Marketplace revenue grew 14% YoY to $232 million, above the midpoint of our guidance range GAAP Marketplace (U.S. Marketplace Segment and Other) operating income of $64.1 million; Non-GAAP Marketplace (U.S. Marketplace Segment and Other) Adjusted EBITDA of $82.4 million, up 18% YoY, above the
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences GlobeNewswire November 06, 2025 SEATTLE, Nov. 06, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in